| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.3 |